IBDEI0J1 ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,8934,1,5,0)
 ;;=5^790.6
 ;;^UTILITY(U,$J,358.3,8934,2)
 ;;=^87228
 ;;^UTILITY(U,$J,358.3,8935,0)
 ;;=274.9^^38^503^12
 ;;^UTILITY(U,$J,358.3,8935,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8935,1,4,0)
 ;;=4^GOUT NOS
 ;;^UTILITY(U,$J,358.3,8935,1,5,0)
 ;;=5^274.9
 ;;^UTILITY(U,$J,358.3,8935,2)
 ;;=^52625
 ;;^UTILITY(U,$J,358.3,8936,0)
 ;;=239.7^^38^503^10
 ;;^UTILITY(U,$J,358.3,8936,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8936,1,4,0)
 ;;=4^ENDOCRINE/NERV NEO NOS
 ;;^UTILITY(U,$J,358.3,8936,1,5,0)
 ;;=5^239.7
 ;;^UTILITY(U,$J,358.3,8936,2)
 ;;=^267785
 ;;^UTILITY(U,$J,358.3,8937,0)
 ;;=255.8^^38^503^2
 ;;^UTILITY(U,$J,358.3,8937,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8937,1,4,0)
 ;;=4^ADRENAL DISORDER NEC
 ;;^UTILITY(U,$J,358.3,8937,1,5,0)
 ;;=5^255.8
 ;;^UTILITY(U,$J,358.3,8937,2)
 ;;=^267874
 ;;^UTILITY(U,$J,358.3,8938,0)
 ;;=255.2^^38^503^4
 ;;^UTILITY(U,$J,358.3,8938,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8938,1,4,0)
 ;;=4^ADRENOGENITAL DISORDERS
 ;;^UTILITY(U,$J,358.3,8938,1,5,0)
 ;;=5^255.2
 ;;^UTILITY(U,$J,358.3,8938,2)
 ;;=^3796
 ;;^UTILITY(U,$J,358.3,8939,0)
 ;;=V15.3^^38^503^13
 ;;^UTILITY(U,$J,358.3,8939,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8939,1,4,0)
 ;;=4^HX OF IRRADIATION
 ;;^UTILITY(U,$J,358.3,8939,1,5,0)
 ;;=5^V15.3
 ;;^UTILITY(U,$J,358.3,8939,2)
 ;;=^295285
 ;;^UTILITY(U,$J,358.3,8940,0)
 ;;=733.00^^38^504^8
 ;;^UTILITY(U,$J,358.3,8940,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8940,1,4,0)
 ;;=4^OSTEOPOROSIS NOS
 ;;^UTILITY(U,$J,358.3,8940,1,5,0)
 ;;=5^733.00
 ;;^UTILITY(U,$J,358.3,8940,2)
 ;;=^87159
 ;;^UTILITY(U,$J,358.3,8941,0)
 ;;=733.01^^38^504^12
 ;;^UTILITY(U,$J,358.3,8941,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8941,1,4,0)
 ;;=4^OSTEOPOROSIS,SENILE
 ;;^UTILITY(U,$J,358.3,8941,1,5,0)
 ;;=5^733.01
 ;;^UTILITY(U,$J,358.3,8941,2)
 ;;=^87188
 ;;^UTILITY(U,$J,358.3,8942,0)
 ;;=733.02^^38^504^11
 ;;^UTILITY(U,$J,358.3,8942,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8942,1,4,0)
 ;;=4^OSTEOPOROSIS,IDIOPATHIC
 ;;^UTILITY(U,$J,358.3,8942,1,5,0)
 ;;=5^733.02
 ;;^UTILITY(U,$J,358.3,8942,2)
 ;;=^272692
 ;;^UTILITY(U,$J,358.3,8943,0)
 ;;=733.03^^38^504^9
 ;;^UTILITY(U,$J,358.3,8943,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8943,1,4,0)
 ;;=4^OSTEOPOROSIS,DISUSE
 ;;^UTILITY(U,$J,358.3,8943,1,5,0)
 ;;=5^733.03
 ;;^UTILITY(U,$J,358.3,8943,2)
 ;;=^265526
 ;;^UTILITY(U,$J,358.3,8944,0)
 ;;=733.09^^38^504^10
 ;;^UTILITY(U,$J,358.3,8944,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8944,1,4,0)
 ;;=4^OSTEOPOROSIS,DRUG-INDUCED
 ;;^UTILITY(U,$J,358.3,8944,1,5,0)
 ;;=5^733.09
 ;;^UTILITY(U,$J,358.3,8944,2)
 ;;=^87762
 ;;^UTILITY(U,$J,358.3,8945,0)
 ;;=268.2^^38^504^6
 ;;^UTILITY(U,$J,358.3,8945,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8945,1,4,0)
 ;;=4^OSTEOMALACIA NOS
 ;;^UTILITY(U,$J,358.3,8945,1,5,0)
 ;;=5^268.2
 ;;^UTILITY(U,$J,358.3,8945,2)
 ;;=^87103
 ;;^UTILITY(U,$J,358.3,8946,0)
 ;;=756.52^^38^504^7
 ;;^UTILITY(U,$J,358.3,8946,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8946,1,4,0)
 ;;=4^OSTEOPETROSIS
 ;;^UTILITY(U,$J,358.3,8946,1,5,0)
 ;;=5^756.52
 ;;^UTILITY(U,$J,358.3,8946,2)
 ;;=^87143
 ;;^UTILITY(U,$J,358.3,8947,0)
 ;;=579.9^^38^504^1
 ;;^UTILITY(U,$J,358.3,8947,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8947,1,4,0)
 ;;=4^MALABSORPTION SYNDROME
 ;;^UTILITY(U,$J,358.3,8947,1,5,0)
 ;;=5^579.9
 ;;^UTILITY(U,$J,358.3,8947,2)
 ;;=^123941
 ;;^UTILITY(U,$J,358.3,8948,0)
 ;;=275.40^^38^504^2
 ;;^UTILITY(U,$J,358.3,8948,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8948,1,4,0)
 ;;=4^METABOLISM D/O,CALCIUM
 ;;^UTILITY(U,$J,358.3,8948,1,5,0)
 ;;=5^275.40
 ;;
 ;;$END ROU IBDEI0J1
